Latest Development Pipeline News

Cyprium Metals has raised A$41 million through an oversubscribed equity placement and entitlement offer to accelerate exploration and production growth at its flagship Nifty Copper Complex and regional projects.

Genesis Energy has reported a robust second-quarter performance for FY26, underpinned by strong hydro generation and record-low thermal output, prompting an upward revision of its full-year earnings guidance. The company’s strategic focus on portfolio flexibility and renewable projects continues to drive margin quality and operational progress.

Noxopharm has successfully completed the final multiple-dose cohort of its HERACLES trial for SOF-SKN™, reporting no significant safety concerns and paving the way for Phase II-enabling studies.

Recce Pharmaceuticals has received a $5.3 million R&D tax rebate from the Australian Taxation Office, providing a significant cash injection to support its innovative synthetic anti-infective drug development programs.

Clinuvel Pharmaceuticals has initiated dosing in a preclinical study of its novel controlled-release injectable peptide platform, VLRX-L, aiming to enhance drug delivery for melanocortin-based therapies. Preliminary results are expected in the second half of 2026.

Robex Resources shareholders have overwhelmingly approved a merger with Predictive Discovery, setting the stage for a leading gold producer in West Africa with combined annual output projected to exceed 400,000 ounces by 2029.

DigiCo Infrastructure REIT has received key regulatory approval to expand its SYD1 data centre in Ultimo, NSW, enabling a significant capacity upgrade amid strong tenant demand.

Lendlease has landed a major contract to develop Sydney’s Hunter Street West Over Station, including a premium 52-storey commercial tower and metro station construction. This deal significantly boosts its development and construction pipeline ahead of FY27.

Finbar Group has conditionally acquired a prime South Perth site for $16.5 million, aiming to launch a $350 million apartment development by 2028 and boosting its pipeline to over $1.6 billion.

Biotron Limited has closed its non-renounceable rights issue, raising $645,861 to advance its Hepatitis B virus drug development, with a shortfall commitment from Peak Asset Management still pending.

Arena REIT reports a $61 million uplift in portfolio valuation for H1 FY2026, driven by strong investor interest in early learning centres and a tightening yield environment. The company reaffirms its FY2026 distribution guidance, signaling confidence in its growth trajectory.

GemLife has secured a $21 million greenfield site in Townsville, Queensland, aiming to develop over 500 new homes and boost its Land Lease Community portfolio.